Pictured: Jedd Wolchok, Alexandra Snyder Charen and Timothy Chan
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, November 20, 2014

In people with melanoma who respond to the drug ipilimumab, certain mutations make tumors more visible to the immune system.

Pictured: Jose Baselga and Maurizio Scaltriti
Finding
By Julie Grisham, MS, Science Writer/Editor  |  Monday, November 17, 2014

A study of one patient’s disease has clarified why tumors stop responding to a class of experimental drugs called PI3K inhibitors.

Gregory Riely
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Wednesday, November 12, 2014

MSK lung cancer patients benefit from a powerful genomic test that looks for mutations in 341 genes to help determine the best treatment.

RISE Program Clinical Director Debra Mangino discusses next steps with a patient.
In the Clinic
By Andrea Peirce, BA, Writer/Editor  |  Friday, October 31, 2014

The team of experts in our RISE Program tailor each woman’s surveillance plan based on the latest findings in breast cancer risk, prevention, and treatment.

SUPPORT
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, October 23, 2014

MSK medical oncologist and acupuncturist Ting Bao discusses the symptoms that arise during breast cancer treatment and how integrative medicine may help relieve them.

DNA wrapped around histones
Decoder
By Julie Grisham, MS, Science Writer/Editor  |  Tuesday, October 14, 2014

Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer.

Pictured: Ping Chi
In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, October 9, 2014

Genetic analysis reveals biomarkers and possible drug targets for malignant peripheral nerve sheath tumors.

Pictured: Robin Roberts & Tonya Samuel
SUPPORT
By Maureen Salamon, BA, Freelance Writer  |  Friday, October 3, 2014

For people undergoing bone marrow or stem cell transplants, being isolated from friends, family, and everyday life can make recovery more difficult.

Event
By Jim Stallard, MA, Writer/Editor  |  Thursday, September 25, 2014

Transplant patients at Memorial Sloan Kettering gave support to bone marrow donation efforts with their own “walk” inside the hospital.

Pictured: James Eastham
Q&A
By Jennifer Bassett, MA, Writer/Editor  |  Tuesday, September 9, 2014

Prostate cancer expert James Eastham talks about Memorial Sloan Kettering’s new outpatient treatment center that will soon open in West Harrison, New York, where he will be practicing.

In the Lab
By Julie Grisham, MS, Science Writer/Editor  |  Thursday, September 4, 2014

Researchers have created tiny structures called organoids from patients’ prostate tumors. These organoids will allow the study of tumors in greater detail and enable correlation of genetic mutations with drug response.

In the Clinic
By Jennifer Castoro, BA, Managing/Copy Editor  |  Thursday, September 4, 2014

Researchers have found that in a subset of women, consumption of soy could boost the expression of genes linked to breast cancer.

Thoracic surgeon Bernard Park.
Ask the Expert
By Andrea Peirce, BA, Writer/Editor  |  Thursday, August 28, 2014

Less trauma and faster recovery are among the reasons that thoracic surgeon Bernard Park says people should consider robotic surgery for removing a cancer in the chest.

Pictured: Michael Stubblefeld
Q&A
By Christina Pernambuco-Holsten, MA  |  Monday, August 25, 2014

Nearly half of all women experience pain or physical limitations after breast cancer surgery. MSK physiatrist Michael Stubblefield answers questions about this condition, known as postmastectomy reconstruction syndrome.

Pictured: Karen Brown & Ghassan Abou-Alfa
Video
By Jenifer Goodwin, BA, Freelance Writer  |  Thursday, August 21, 2014

Watch our liver cancer experts discuss the latest in screening, diagnosis, treatment, and research.

Center News

Stay Informed

Get the latest information about cancer care and research every month.